<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/differentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/differentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2013-11-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2013-11-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/differentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup/"},"url":"https://clinicaltree.github.io/posts/differentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup/"}</script><title>Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Differentiating Calcium Oxalate and Hydroxyapatite Stones In Vivo Using Dual-Energy CT and Urine Supersaturation and pH Values</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1385830800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Nov 30, 2013 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Yu Liu MD PhD</a> </em>, <em> <a href="">Mingliang Qu MD</a> </em>, <em> <a href="">Rickey E. Carter PhD</a> </em>, <em> <a href="">Shuai Leng PhD</a> </em>, <em> <a href="">Juan Carlos Ramirez-Giraldo PhD</a> </em>, <em> <a href="">Giselle Jaramillo BS</a> </em>, <em> <a href="">Amy E. Krambeck MD</a> </em>, <em> <a href="">John C. Lieske MD</a> </em>, <em> <a href="">Terri J. Vrtiska MD</a> </em>, <em> <a href="">Cynthia H. McCollough PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1645 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Knowledge of urinary stone composition can guide therapeutic intervention for patients with calcium oxalate (CaOx) or hydroxyapatite (HA) stones. In this study, we determined the accuracy of noninvasive differentiation of these two stone types using dual-energy CT (DECT) and urine supersaturation (SS) and pH values.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Patients who underwent clinically indicated DECT scanning for stone disease and subsequent surgical intervention were enrolled. Stone composition was determined using infrared spectroscopy. DECT images were processed using custom-developed software that evaluated the ratio of CT numbers between low- and high-energy images. Clinical information, including patient age, gender, and urine pH and supersaturation profile, was obtained from electronic medical records. Simple and multiple logistic regressions were used to determine if the ratio of CT numbers could discriminate CaOx from HA stones alone or in conjunction with urine supersaturation and pH.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Urinary stones (CaOx <em>n</em> = 43, HA <em>n</em> = 18) from 61 patients were included in this study. In a univariate model, DECT data, urine SS-HA, and urine pH had an area under the receiver operating characteristic curve of 0.78 (95% confidence interval [CI] 0.66–0.91, <em>P</em> = .016), 0.76 (95% CI 0.61–0.91, <em>P</em> = .003), and 0.60 (95% CI 0.44–0.75, <em>P</em> = .20), respectively, for predicting stone composition. The combination of CT data and the urinary SS-HA had an area under the receiver operating characteristic curve of 0.79 (95% CI 0.66–0.92, <em>P</em> = .007) for correctly differentiating these two stone types.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>DECT differentiated between CaOx and HA stones similarly to SS-HA, whereas pH was a poor discriminator. The combination of DECT and urine SS or pH data did not improve this performance.</p><p>Urinary tract stones (urolithiasis) are one of the most common causes of acute and chronic pain causing significant morbidity. The lifetime incidence in developed countries is about 10% to 15%, with a relapse rate of 50% in 10 years and 75% in 20 years . One of the key factors for optimizing the management of patients with urolithiasis is the chemical composition of the stone . Medical treatment, preoperative evaluation, and the strategy for recurrence prevention are all influenced by stone type. For example, because uric acid stones can dissolve in urine of higher pH, alkalization of the urine is often effective. Extracorporeal shock wave lithotripsy is commonly used for stone removal , but certain firm stones, such as brushite and some calcium oxalate (CaOx) stones, resist fragmentation. Overall, unnecessary procedures can potentially be avoided if the chemical composition is readily known in the initial stage of patient evaluation .</p><p>About 80% of stones are composed of CaOx and/or hydroxyapatite (HA) . These two stone types form under different physiochemical conditions, making the differentiation between the two stone types desirable for both research and treatment purposes . Twenty-four-hour urine collection used to measure key components in the urine is the most common method to assess kidney stone risk factors. For example, CaOx stones can form under a wide range of physiologic urinary pH conditions, while HA stones tend to form in alkaline urine . Urinary supersaturation (SS) calculated from the composition of a twenty-four-hour urine collection also correlates with the crystalline component of the stones passed . Therefore, physicians rely largely on urine pH and urine SS profile to predict stone composition when a previous stone analysis is not available.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patient-inclusion"><span class="mr-2">Patient Inclusion</span><a href="#patient-inclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-ct-data-acquisition-and-image-processing"><span class="mr-2">Clinical CT Data Acquisition and Image Processing</span><a href="#clinical-ct-data-acquisition-and-image-processing" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/0_1s20S107663321300398X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/0_1s20S107663321300398X.jpg" alt="Figure 1, Two sample images show characterization of stone compositions. (a) A 61-year-old female patient with urine pH 6.8 and supersaturation calcium oxalate of 1.12 and supersaturation hydroxyapatite of 3.2 and (b) a 67-year-old female patient with urine pH 6.1, supersaturation calcium oxalate of 0.52, and supersaturation hydroxyapatite of 3.22. Stone compositions were hard to predict using these lab values, while dual-energy computed tomography determined them correctly to be (a) a calcium oxalate stone and (b) an hydroxyapatite stone." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="clinical-lab-urine-evaluations"><span class="mr-2">Clinical Lab Urine Evaluations</span><a href="#clinical-lab-urine-evaluations" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Dual-energy CTR, SS-HA, SS-CaOx, and Urine pH of CaOx and HA Stone Patients</p><p>CaOx HA_P_ Value Mean ± SD Range Mean ± SD Range CTR 1.40 ± 0.13 1.17 to 1.68 1.49 ± 0.11 1.35 to 1.71 .016 SS-HA, D.G. 3.29 ± 1.95 −1.94 to 6.72 5.43 ± 2.67 −0.74 to 9.36 &lt;.01 SS-CaOx, D.G. 1.85 ± 0.57 0.29 to 2.86 1.68 ± 0.64 0.45 to 2.54 .32 Urine pH 6.0 ± 0.7 4.7 to 7.5 6.2 ± 0.6 5.2 to 7.6 .20</p><p>CaOx, calcium oxalate; CTR, computed tomography number ratio; D.G., delta gibbs; HA, hydroxyapatite; SD, standard deviation; SS, supersaturation.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/1_1s20S107663321300398X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/1_1s20S107663321300398X.jpg" alt="Figure 2, Box-plots of (a) dual-energy CT number ratio (CTR), (b) supersaturation hydroxyapatite, D.G., and (c) urine pH for calcium oxalate and hydroxyapatite stones." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/2_1s20S107663321300398X.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/DifferentiatingCalciumOxalateandHydroxyapatiteStonesInVivoUsingDualEnergyCTandUrineSupersaturationandpHValues/2_1s20S107663321300398X.jpg" alt="Figure 3, Receiver operating characteristic (ROC) curves of (a) dual-energy CT ratio (CTR) ( P = .016) and (b) supersaturation hydroxyapatite ( P &lt; .01) and (c) urine pH ( P = .20) for calcium oxalate and hydroxyapatite stone discrimination." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Summary of Statistical Analysis Result Using One or Combination of Variables as Predictor(s) of Stone Type</p><p>Variable(s) Area Under ROC Curve (C-statistic) 95% Confidence Interval_P_ Value CTR 0.78 0.66–0.91 .016 SS-HA 0.76 0.61–0.91 .003 SS-CaOx 0.57 0.42–0.73 .32 Urine pH 0.60 0.44–0.75 .20 CTR + SS-HA 0.79 0.66–0.92 .007 ∗ CTR + urine pH 0.77 0.65–0.88 .02 ∗ CTR + SS-HA + urine pH 0.80 0.67–0.92 .07 ∗</p><p>CaOx, calcium oxalate; CTR, computed tomography number ratio; HA, hydroxyapatite; SS, supersaturation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion-and-conclusion"><span class="mr-2">Discussion and conclusion</span><a href="#discussion-and-conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Pak C.Y.: Kidney stones. Lancet 1998; 351: pp. 1797-1801.</p><li><p>2. Moe O.W.: Kidney stones: pathophysiology and medical management. Lancet 2006; 367: pp. 333-344.</p><li><p>3. Barcelo P., Wuhl O., Servitge E., et. al.: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: pp. 1761-1764.</p><li><p>4. Klee L.W., Brito C.G., Lingeman J.E.: The clinical implications of brushite calculi. J Urol 1991; 145: pp. 715-718.</p><li><p>5. Daudon M., Donsimoni R., Hennequin C., et. al.: Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy. Urol Res 1995; 23: pp. 319-326.</p><li><p>6. Pak C.Y., Poindexter J.R., Adams-Huet B., et. al.: Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 2003; 115: pp. 26-32.</p><li><p>7. Coe F.L., Evan A., Worcester E.: Kidney stone disease. J Clin Invest 2005; 115: pp. 2598-2608.</p><li><p>8. Parks J.H., Worcester E.M., Coe F.L., et. al.: Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int 2004; 66: pp. 777-785.</p><li><p>9. Parks J.H., Coward M., Coe F.L.: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 1997; 51: pp. 894-900.</p><li><p>10. Asplin J., Parks J., Lingeman J., et. al.: Supersaturation and stone composition in a network of dispersed treatment sites. J Urol 1998; 159: pp. 1821-1825.</p><li><p>11. Gault M.H., Parfrey P.S., Robertson W.G.: Idiopathic calcium phosphate nephrolithiasis. Nephron 1988; 48: pp. 265-273.</p><li><p>12. Smith R.C., Verga M., McCarthy S., et. al.: Diagnosis of acute flank pain: value of unenhanced helical CT. AJR Am J Roentgenol 1996; 166: pp. 97-101.</p><li><p>13. Primak A.N., Fletcher J.G., Vrtiska T.J., et. al.: Noninvasive differentiation of uric acid versus non-uric acid kidney stones using dual-energy CT. Acad Radiol 2007; 14: pp. 1441-1447.</p><li><p>14. Graser A., Johnson T.R., Bader M., et. al.: Dual energy CT characterization of urinary calculi: initial in vitro and clinical experience. Invest Radiol 2008; 43: pp. 112-119.</p><li><p>15. Matlaga B.R., Kawamoto S., Fishman E.: Dual source computed tomography: a novel technique to determine stone composition. Urology 2008; 72: pp. 1164-1168.</p><li><p>16. Boll D.T., Patil N.A., Paulson E.K., et. al.: Renal stone assessment with dual-energy multidetector CT and advanced postprocessing techniques: improved characterization of renal stone composition–pilot study. Radiology 2009; 250: pp. 813-820.</p><li><p>17. Qu M., Ramirez-Giraldo J.C., Leng S., et. al.: Dual-Energy Dual-Source CT With Additional Spectral Filtration Can Improve the Differentiation of Non-Uric Acid Renal Stones: An Ex Vivo Phantom Study. Am J Roentgenol 2011; 196: pp. 1279-1287.</p><li><p>18. Qu M., Jaramillo-Alvarez G., Ramirez-Giraldo J.C., et. al.: Urinary stone differentiation in patients with large body size using dual-energy dual-source computed tomography. Eur Radiol 2012;</p><li><p>19. Krambeck A.E., Khan N.F., Jackson M.E., et. al.: Inaccurate reporting of mineral composition by commercial stone analysis laboratories: implications for infection and metabolic stones. J Urol 2010; 184: pp. 1543-1549.</p><li><p>20. Werness P.G., Brown C.M., Smith L.H., et. al.: EQUIL2: a BASIC computer program for the calculation of urinary saturation. J Urol 1985; 134: pp. 1242-1244.</p><li><p>21. Schubert G.: Stone analysis. Urol Res 2006; 34: pp. 146-150.</p><li><p>22. Levy F.L., Adams-Huet B., Pak C.Y.: Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 1995; 98: pp. 50-59.</p><li><p>23. Lingeman J., Kahnoski R., Mardis H., et. al.: Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol 1999; 161: pp. 1077-1081.</p><li><p>24. Coe F.L., Evan A.P., Lingeman J.E., et. al.: Plaque and deposits in nine human stone diseases. Urol Res 2010; 38: pp. 239-247.</p><li><p>25. Evan A.P., Lingeman J.E., Coe F.L., et. al.: Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Investig 2003; 111: pp. 607-616.</p><li><p>26. Evan A.P., Lingeman J., Coe F., et. al.: Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int 2007; 71: pp. 795-801.</p><li><p>27. Evan A.P.: Physiopathology and etiology of stone formation in the kidney and the urinary tract. Pediatr Nephrol 2010; 25: pp. 831-841.</p><li><p>28. Mandel N., Mandel I., Fryjoff K., et. al.: Conversion of calcium oxalate to calcium phosphate with recurrent stone episodes. J Urol 2003; 169: pp. 2026-2029.</p><li><p>29. Krambeck A.E., Handa S.E., Evan A.P., et. al.: Brushite stone disease as a consequence of lithotripsy?. Urol Res 2010; 38: pp. 293-299.</p><li><p>30. Yu L., Primak A.N., Liu X., et. al.: Image quality optimization and evaluation of linearly mixed images in dual-source, dual-energy CT. Med Phys 2009; 36: pp. 1019-1024.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-20/'>Volume 20</a>, <a href='/categories/issue-12/'>Issue 12</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Differentiating%20Calcium%20Oxalate%20and%20Hydroxyapatite%20Stones%20In%20Vivo%20Using%20Dual-Energy%20CT%20and%20Urine%20Supersaturation%20and%20pH%20Values%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Differentiating%20Calcium%20Oxalate%20and%20Hydroxyapatite%20Stones%20In%20Vivo%20Using%20Dual-Energy%20CT%20and%20Urine%20Supersaturation%20and%20pH%20Values%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fdifferentiating-calcium-oxalate-and-hydroxyapatite-stones-in-vivo-using-dual-energy-ct-and-urine-sup%2F&text=Differentiating%20Calcium%20Oxalate%20and%20Hydroxyapatite%20Stones%20In%20Vivo%20Using%20Dual-Energy%20CT%20and%20Urine%20Supersaturation%20and%20pH%20Values%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-picture-is-worth-a-thousand-words/"><div class="card-body"> <em class="small" data-ts="1385830800" data-df="ll" > Nov 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Picture Is Worth A Thousand Words</h3><div class="text-muted small"><p> Rationale and Objectives Radiology reports are the major, and often only, means of communication between radiologists and their referring clinicians. The purposes of this study are to identify ref...</p></div></div></a></div><div class="card"> <a href="/posts/a-retrieval-based-computer-aided-diagnosis-system-for-the-characterization-of-liver-lesions-in-ct-sc/"><div class="card-body"> <em class="small" data-ts="1385830800" data-df="ll" > Nov 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Retrieval-Based Computer-Aided Diagnosis System for the Characterization of Liver Lesions in CT Scans</h3><div class="text-muted small"><p> Rationale and Objectives To evaluate a computer-aided diagnosis (CADx) system for the characterization of liver lesions in computed tomography (CT) scans. The stand-alone predictive performance of...</p></div></div></a></div><div class="card"> <a href="/posts/academic-radiology-in-the-new-health-care-delivery-environment/"><div class="card-body"> <em class="small" data-ts="1385830800" data-df="ll" > Nov 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Academic Radiology in the New Health Care Delivery Environment</h3><div class="text-muted small"><p> Rationale and Objectives Ongoing concerns over the rising cost of health care are driving large-scale changes in the way that health care is practiced and reimbursed in the United States. Materia...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/comparison-of-three-different-mr-perfusion-techniques-and-mr-spectroscopy-for-multiparametric-assess/" class="btn btn-outline-primary" prompt="Older"><p>Comparison of Three Different MR Perfusion Techniques and MR Spectroscopy for Multiparametric Assessment in Distinguishing Recurrent High-Grade Gliomas from Stable Disease</p></a> <a href="/posts/diffusion-weighted-imaging-of-prostate-cancer-on-3t-mr/" class="btn btn-outline-primary" prompt="Newer"><p>Diffusion-Weighted Imaging of Prostate Cancer on 3T MR</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
